Treatment of Pinguecula
For symptomatic pinguecula with inflammation, topical indomethacin 0.1% solution is the preferred first-line treatment, administered 4-6 times daily for 2 weeks, as it provides equivalent efficacy to corticosteroids without the risk of rebound inflammation upon discontinuation. 1, 2
Conservative Management Approach
Asymptomatic Pinguecula
- No treatment is necessary for asymptomatic pinguecula, as these are benign lesions that do not affect vision 3
- Observation alone is appropriate when patients have no complaints of irritation, redness, or cosmetic concerns 3
Symptomatic Pinguecula - First-Line Therapy
Topical NSAIDs are the treatment of choice:
- Indomethacin 0.1% solution should be administered 6 times daily for 3 days, then reduced to 4 times daily for 11 additional days 1
- This regimen significantly reduces both objective signs (conjunctival congestion, redness, edema) and subjective symptoms (photophobia, pain, foreign body sensation, tearing) within 3 days 1
- Improvement continues progressively through day 14 of treatment 1
- Patients should expect mild stinging lasting less than 1 minute after drop administration 1
Alternative Anti-Inflammatory Options
If indomethacin is unavailable or not tolerated:
- Dexamethasone phosphate 0.1% solution can be used with the same dosing schedule (6 times daily for 3 days, then 4 times daily for 11 days) 2
- However, corticosteroids carry a significant disadvantage: rebound inflammation occurs after discontinuation, with recurrence of signs being significantly greater at 2-4 weeks post-treatment compared to indomethacin 2
- Preservative-free formulations should be prioritized when using topical corticosteroids to minimize additional conjunctival irritation 4
Adjunctive Symptomatic Relief
- Preservative-free artificial tears can be used for minor irritation and dryness symptoms 3
- These provide lubrication but do not address the underlying inflammation 3
Novel Experimental Therapies
- Topical dipyridamole in normal saline solution has shown promise in a single case report, with regression of tissue and resolution of symptoms over 12 months 5
- However, this remains investigational and requires further study before routine clinical use 5
Important Clinical Pitfalls
Avoid these common errors:
- Do not confuse pinguecula with pterygium - pinguecula does not cross the limbus onto the cornea, while pterygium does 6, 3
- Do not rush to surgery - pinguecula rarely requires surgical intervention, unlike pterygium which may affect the visual axis 3
- Do not use corticosteroids as first-line therapy - while effective, they cause more rebound inflammation than NSAIDs after discontinuation 2
- Do not ignore persistent symptoms - if inflammation does not respond to 2 weeks of topical NSAIDs, reassess the diagnosis to exclude other conditions 1